EMJ GOLD

Filter Advertise With Us

First daily GLP-1 pill approved in UK

Novo Nordisk’s semaglutide tablets have become the first once-daily GLP-1 pills to be approved in the UK.

First daily GLP-1 pill approved in UK

Novo Nordisk’s semaglutide tablets have become the first once-daily GLP-1 pills to be approved in the UK.

Two people shaking hands over a desk

New biotech boom: Biogen to buy RayThera for $1bn

Is the biotech boom back? Biogen becomes the latest large pharma company to snap up a promising biotech.

GSK’s antibiotic for complicated UTIs wins FDA approval

The FDA has approved GSK’s antibiotic for adults with complicated UTIs, providing a promising alternative to standard intravenous care.

World Cup 2026 ball on grassy pitch

Pharma backs FIFA World Cup 2026 host cities

Genentech, Amgen, Sanofi and BMS have each announced partnerships with host city organising committees.

Pharma supply chains face record pressure as four risks converge

Pharmaceutical supply chains under mounting pressure from geopolitical disruption, manufacturing fragility, cyber threats and more.

England launches MenB vaccine programme for students

England launches one-off MenB vaccination programme for students

Thousands of young people in England will be offered a two-dose MenB vaccine ahead of the 2026 academic year.

Pharmacist compounding a drug

FDA steps up crackdown on compounded GLP-1s

Around 1.5 million Americans are taking compounded GLP-1 drugs despite the end of US shortages.

GSK office building

GSK to acquire Nuvalent for $10.6bn ahead of patent cliff

The purchase, GSK’s biggest in over a decade, includes two late-stage lung cancer drugs primed for FDA approval.

Loading posts...

1 2 3 … 53 Next »